Castle Biosciences Secures $11,700,000 Series F Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=94f0fb64-7245-43a5-b353-f0abd2c275bb - Date
7/27/2015 - Company Name
Castle Biosciences - Mailing Address
2014 San Miguel Dr. Friendswood, TX 77546 USA - Company Description
Castle Biosciences develops and commercializes diagnostic and prognostic tests for cancers that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes. - Website
http://www.castlebiosciences.com - Transaction Type
Venture Equity - Transaction Amount
$11,700,000 - Transaction Round
Series F - Proceeds Purposes
The funding will be used to accelerate the growth in clinical adoption of the Company’s gene test for identifying metastatic risk in early stage cutaneous melanoma, DecisionDx-Melanoma, and its other tests designed to improve cancer care. - M&A Terms
- Venture Investor
Industry Ventures - Venture Investor
HealthQuest Capital - Venture Investor
Mountain Group Capital
